scispace - formally typeset
M

Mathieu F. Janssen

Researcher at Erasmus University Rotterdam

Publications -  62
Citations -  9751

Mathieu F. Janssen is an academic researcher from Erasmus University Rotterdam. The author has contributed to research in topics: EQ-5D & Population. The author has an hindex of 18, co-authored 45 publications receiving 6447 citations. Previous affiliations of Mathieu F. Janssen include University of Amsterdam & Academic Medical Center.

Papers
More filters
Journal ArticleDOI

Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)

TL;DR: A 5-level version of the EQ-5D has been developed by the EuroQol Group and further testing is required to determine whether the new version improves sensitivity and reduces ceiling effects.
Journal ArticleDOI

Interim Scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L Value Sets

TL;DR: The nonparametric model was preferred for its simplicity while performing similarly to the other models, and being independent of the value set that is used, it can be applied to transform any EQ-5D-3L value set into EQ- 5D-5L index values.
Journal ArticleDOI

Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: A multi-country study

TL;DR: The EQ-5D-5L appears to be a valid extension of the 3-level system which improves upon the measurement properties, reducing the ceiling while improving discriminatory power and establishing convergent and known-groups validity.
Journal ArticleDOI

Comparing the standard EQ-5D three-level system with a five-level version.

TL;DR: The EQ-5D five-level version appears a valid and reliable extension of the three-level system and is particularly useful for describing mild health problems and monitoring population health.
Journal ArticleDOI

Is EQ-5D-5L Better Than EQ-5D-3L? A Head-to-Head Comparison of Descriptive Systems and Value Sets from Seven Countries

TL;DR: 5L provides more precise measurement at individual and group levels, both in terms of descriptive system data and utilities, which is likely to be generalisable to longitudinal studies, including economic evaluation, clinical and public health studies.